| Blood Pressure and Hypertension Studies | Lifetime | 348 | GR 6 | 98.91 |
| Renal and Vascular Pathologies | Lifetime | 221 | GR 1 | 98.46 |
| Dialysis and Renal Disease Management | Lifetime | 254 | GR 1 | 98.67 |
| Hormonal Regulation and Hypertension | Lifetime | 339 | GR 2 | 98.37 |
| Hemodynamic Monitoring and Therapy | Lifetime | 291 | GR 2 | 98.16 |
| Cardiovascular Health and Disease Prevention | Lifetime | 414 | GR 10 | 98.07 |
| Chronic Kidney Disease and Diabetes | Lifetime | 299 | GR 1 | 98.34 |
| Diabetes Treatment and Management | Lifetime | 546 | GR 3 | 98.05 |
| Electrolyte and hormonal disorders | Lifetime | 378 | GR 3 | 96.58 |
| Sodium Intake and Health | Lifetime | 180 | GR 3 | 97.01 |
| Pharmacology and Obesity Treatment | Lifetime | 373 | GR 3 | 95.96 |
| Potassium and Related Disorders | Lifetime | 203 | GR 2 | 96.16 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 894 | GR 4 | 95.05 |
| Ultrasound in Clinical Applications | Lifetime | 772 | GR 4 | 92.78 |
| Magnesium in Health and Disease | Lifetime | 971 | GR 5 | 81.53 |
| Renal and Vascular Pathologies | 2021-2025 | 6 | GR 1 | 99.40 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 33 | GR 3 | 99.27 |
| Hormonal Regulation and Hypertension | 2021-2025 | 20 | GR 1 | 99.00 |
| Dialysis and Renal Disease Management | 2021-2025 | 68 | GR 1 | 98.26 |
| Diabetes Treatment and Management | 2021-2025 | 177 | GR 2 | 98.02 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 86 | GR 2 | 96.46 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 106 | GR 4 | 95.58 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 187 | GR 1 | 95.57 |
| Heart Failure Treatment and Management | 2021-2025 | 417 | GR 4 | 94.96 |
| Sodium Intake and Health | 2021-2025 | 95 | GR 3 | 91.31 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 587 | GR 13 | 90.13 |
| Electrolyte and hormonal disorders | 2021-2025 | 110 | GR 1 | 89.94 |
| Potassium and Related Disorders | 2021-2025 | 96 | GR 2 | 91.93 |
| Peripheral Artery Disease Management | 2021-2025 | 691 | GR 7 | 86.56 |
| Ultrasound in Clinical Applications | 2021-2025 | 559 | GR 2 | 81.27 |
| Ion Transport and Channel Regulation | 2021-2025 | 240 | GR 2 | 75.42 |
| Neurological Complications and Syndromes | 2021-2025 | 263 | GR 1 | 74.66 |
| Renal function and acid-base balance | 2021-2025 | 282 | GR 3 | 72.80 |
| Renin-Angiotensin System Studies | 2021-2025 | 339 | GR 1 | 58.53 |
| Pharmacology and Obesity Treatment | 2021-2025 | 971 | GR 15 | 58.57 |
| Heart rate and cardiovascular health | 2021-2025 | 139 | GR 3 | 54.08 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 609 | GR 10 | 42.95 |
| Neurological and metabolic disorders | 2021-2025 | 830 | GR 7 | 36.15 |
